Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressure-volume loops in rats

被引:33
作者
Bal, Miriam P. [1 ,2 ]
de Vries, Willem B. [2 ]
van Oosterhout, Matthijs F. M. [3 ]
Baan, Jan [1 ]
van der Wall, Ernst E. [1 ]
van Bel, Frank [2 ]
Steendijk, Paul [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[2] Univ Utrecht, Dept Neonatol, Med Ctr, Utrecht, Netherlands
[3] Univ Utrecht, Dept Pathol, Med Ctr, Utrecht, Netherlands
关键词
cardiac function; pressure-volume relations; rats; glucocorticoids;
D O I
10.1152/japplphysiol.00951.2007
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Dexamethasone is clinically applied in preterm infants to treat or prevent chronic lung disease. However, concern has emerged about adverse side effects. The cardiovascular short-term side effects of neonatal dexamethasone treatment are well documented, but long-term consequences are unknown. Previous studies showed suppressed mitosis during dexamethasone treatment, leading to reduced ventricular weight, depressed systolic function, and compensatory dilatation in prepubertal rats. In addition, recent data indicated a reduced life expectancy. Therefore, we investigated the long-term effects of neonatal dexamethasone treatment on cardiovascular function. Neonatal rats were treated with dexamethasone or received saline. Cardiac function was determined in 8-, 50-, and 80-wk-old animals, representing young adult, middle-aged, and elderly stages. A pressure-conductance catheter was introduced into the left ventricle to measure pressure-volume loops. Subsequently, the hearts were collected for histological examination. Our results showed reduced ventricular and body weights in dexamethasone-treated rats at 8 and 80 wk, but not at 50 wk. Cardiac output and diastolic function were unchanged, but systolic function was depressed at 50 and 80 wk, evidenced by reduced ejection fractions and rightward shifts of the end-systolic pressure-volume relationships. We concluded that previously demonstrated early adverse effects of neonatal dexamethasone treatment are transient but that reduced ventricular weight and systolic dysfunction become manifest again in elderly rats. Presumably, cellular hypertrophy initially compensates for the dexamethasone treatment-induced lower number of cardiomyocytes, but this mechanism falls short at a later stage, leading to systolic dysfunction. If applicable to humans, cardiac screening of a relatively large patient group to enable secondary prevention may be indicated.
引用
收藏
页码:446 / 450
页数:5
相关论文
共 41 条
[1]   CONTINUOUS MEASUREMENT OF LEFT-VENTRICULAR VOLUME IN ANIMALS AND HUMANS BY CONDUCTANCE CATHETER [J].
BAAN, J ;
VANDERVELDE, ET ;
DEBRUIN, HG ;
SMEENK, GJ ;
KOOPS, J ;
VANDIJK, AD ;
TEMMERMAN, D ;
SENDEN, J ;
BUIS, B .
CIRCULATION, 1984, 70 (05) :812-823
[2]   Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences? [J].
Bakker, JM ;
van Bel, F ;
Heijnen, CJ .
TRENDS IN NEUROSCIENCES, 2001, 24 (11) :649-653
[3]   Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilatation in early life: Studies in 4-week-old prepubertal rats [J].
Bal, MP ;
De Vries, WB ;
Van der Leij, FR ;
Van Oosterhout, MFM ;
Berger, RMF ;
Baan, J ;
Van der Wall, EE ;
Van Bel, F ;
Steendjk, P .
PEDIATRIC RESEARCH, 2005, 58 (01) :46-52
[4]   The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs [J].
Barrington K.J. .
BMC Pediatrics, 1 (1)
[5]   Postnatal steroids and neurodevelopmental outcomes: A problem in the making [J].
Barrington, KJ .
PEDIATRICS, 2001, 107 (06) :1425-1426
[6]  
Bensky AS, 1996, PEDIATRICS, V97, P818
[7]   HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AS A SIDE-EFFECT OF DEXAMETHASONE TREATMENT FOR BRONCHOPULMONARY DYSPLASIA [J].
BRAND, PLP ;
VANLINGEN, RA ;
BRUS, F ;
TALSMA, MD ;
ELZENGA, NJ .
ACTA PAEDIATRICA, 1993, 82 (6-7) :614-617
[8]  
BURCHFIELD DJ, 2002, PEDIATRICS, V109, P330
[9]   Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers [J].
Burkhoff, D ;
Mirsky, I ;
Suga, H .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (02) :H501-H512
[10]   Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment [J].
de Vries, WB ;
Bal, MP ;
Homoet-van der Kraak, P ;
Kamphuis, PJGH ;
van der Leij, FR ;
Baan, J ;
Steendijk, P ;
de Weger, RA ;
van Bel, F ;
van Oosterhout, MFM .
BASIC RESEARCH IN CARDIOLOGY, 2006, 101 (01) :36-42